Oaktree Acquisition Corp. III Reports $7.3 Million Net Income for 2025

Oaktree Acquisition Corp. III Life Sciences, a blank check company incorporated in the Cayman Islands, reported a net income of $7.3 million for the year ending December 31, 2025, primarily driven by interest income from its trust account. This figure represents a significant increase from the previous fiscal period, where the company recorded a net income of $1.3 million. The increase in income is attributed to higher interest earned on cash held in the trust account, which amounted to approximately $8.5 million, offset by general and administrative expenses of $1.2 million.

The company has not yet identified a specific target for its initial business combination, which it aims to complete within 24 months of its initial public offering (IPO). As of December 31, 2025, Oaktree Acquisition Corp. III had approximately $201.6 million in its trust account, which is intended to be used for the business combination. The company also reported $1.4 million in cash held outside the trust account, which will be utilized for operational expenses and due diligence related to potential acquisition targets.

Strategically, Oaktree Acquisition Corp. III is focused on the healthcare sector, leveraging the expertise of its management team, which has extensive experience in identifying and acquiring businesses in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors. The company plans to capitalize on Oaktree's established network and investment experience to identify suitable acquisition opportunities. The management team has previously executed successful business combinations through other SPACs, enhancing their credibility in the market.

Operationally, the company has incurred significant costs related to its search for a target business, and it anticipates that these costs will continue as it pursues its acquisition strategy. The management team consists of three executive officers, who are not obligated to commit a specific amount of time to the company, potentially leading to conflicts of interest as they balance their responsibilities across multiple ventures. As of the filing date, there were no material legal proceedings against the company, and it has maintained its corporate office in Los Angeles, California.

Looking ahead, Oaktree Acquisition Corp. III faces challenges typical of SPACs, including competition for attractive acquisition targets and the need to complete a business combination within the specified timeframe. The company has expressed confidence in its ability to identify a suitable target and execute a successful business combination, but it acknowledges the inherent risks and uncertainties associated with the process. If the company fails to complete a business combination within the required period, it may be forced to liquidate, which could result in public shareholders receiving less than the initial $10.00 per share.